Bomin Kim

Private Equity Sponsor Transactions

• Carlyle Group in its majority stake acquisition in Beautycounter, the leader in clean beauty products, accelerating its strategic initiatives and increasing brand awareness
• Private equity firm in its contemplated acquisition of a company that provides IT initiatives to colleges and universities
• Private equity firm in its contemplated acquisition of an engineering, technical, IT, and scientific services firm

Public Company Representations

• Pharmaceutical company in its contemplated acquisition of a medical technology company

IP Litigation

• Representing Microspherix in patent litigation involving Merck’s implantable contraceptive Nexplanon (etonogestrel implant); successfully defended client’s patent estate in inter partes review proceedings before the USPTO
• Represented Teva in an ANDA case against Merck concerning the drug alvimopan (Entereg®)
• Represented Abbott Cardiovascular, successfully defending against five inter partes review petitions filed by Edwards Lifesciences challenging Abbott’s patents covering MitraClip®, resulting in denial of all five petitions
• Represented Samsung Electronics against WiNet Labs LLC (S.D.N.Y.) in its defense of a patent infringement action related to ad-hoc network methods

Summer Associate, Kirkland & Ellis LLP

Summer Associate, Baker Botts LLP

Technical Advisor, Lex IP Meister, LLP